Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R. Litzow, Martin S. Tallman, Zhuoxin Sun et al.|New England Journal of Medicine|2024Cited by 213
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patientsErika Morsia, Naseema Gangat, Kristen McCullough et al.|American Journal of Hematology|2020Cited by 136
Posttransplantation Thrombotic Thrombocytopenic Purpura: A Single-Center Experience and a Contemporary ReviewMichelle A. Elliott, Mark R. Litzow, Martha Q. Lacy et al.|Mayo Clinic Proceedings|2003Cited by 110
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative studySabine Käyser, Mark J. Levis, Sandra Casal Marini et al.|Haematologica|2021Cited by 34
Venetoclax plus hypomethylating agent in blast‐phase myeloproliferative neoplasm: preliminary experience with 12 patientsNaseema Gangat, Ayalew Tefferi, Erika Morsia et al.|British Journal of Haematology|2020Cited by 20